Immunic, Inc.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Immunic, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 61 | 57 | −4 |
| Shares | 57.4M | 55.8M | −1.53M (−2.7%) |
| Value | $75.7M | $62.1M | −$13.7M (−18.0%) |
New holders (4)
Institutions that held Immunic, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jefferies Financial Group Inc. | 331,774 | $368.3K | 0.01% |
| Bank of Montreal | 284,109 | $321.0K | 0.00% |
| Gsa Capital Partners LLP | 116,765 | $130.0K | 0.01% |
| Qube Research & Technologies Ltd | 51 | $56 | 0.00% |
Sold out (8)
Institutions that held Immunic, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Logos Global Management LP | 421,184 | $556.0K |
| Acadian Asset Management LLC | 239,962 | $316.0K |
| D. E. Shaw & Co., Inc. | 52,275 | $69.0K |
| American Century Companies Inc | 20,942 | $27.6K |
| Virtu Financial LLC | 19,088 | $25.0K |
| Goldman Sachs Group Inc | 13,814 | $18.2K |
| Balboa Wealth Partners | 12,000 | $15.8K |
| Vontobel Holding Ltd. | 10,000 | $13.2K |